---
title: 'Inflammation, Lp(a) and cardiovascular mortality: results from the LURIC study'
date: '2025-02-06'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39912915/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250206170938&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: HsCRP and IL-6 are associated with cardiovascular mortality.
  Markedly elevated Lp(a) is associated with an increased risk of cardiovascular mortality
  in the context of high systemic inflammation. Anti-inflammatory treatments may provide
  additional therapeutic benefits for individuals with high ...'
disable_comments: true
---
CONCLUSION: HsCRP and IL-6 are associated with cardiovascular mortality. Markedly elevated Lp(a) is associated with an increased risk of cardiovascular mortality in the context of high systemic inflammation. Anti-inflammatory treatments may provide additional therapeutic benefits for individuals with high ...